awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50001044-20D6C0C6-81D6-4414-9857-25EA5CEE65A8
Q50001044-20D6C0C6-81D6-4414-9857-25EA5CEE65A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50001044-20D6C0C6-81D6-4414-9857-25EA5CEE65A8
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.
P2860
Q50001044-20D6C0C6-81D6-4414-9857-25EA5CEE65A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50001044-20D6C0C6-81D6-4414-9857-25EA5CEE65A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5b9571b92eb7658aba13fe9e66da62e891f3749
P2860
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.